If one kidney is removed, can cancer grow in the other? The honest answer, and what it depends on

It can, but it is uncommon. Most people who have a kidney removed for cancer never develop a tumour in the remaining one. When it does happen it is a new, separate cancer that has arisen in that kidney on its own account, not the original tumour moving across. There is no channel between the two kidneys for a cancer to travel along. What carries over is the set of reasons the first cancer appeared in the first place, such as an inherited syndrome or long-standing dialysis, and those same reasons can act on the kidney that is still there. This is precisely why follow-up imaging of the abdomen looks at the remaining kidney every time.

Usually it is treated as a new, second cancer rather than a recurrence, because it has arisen in fresh tissue rather than regrown from the original site. The distinction matters, because a genuine recurrence of the first cancer far more often turns up in the lungs, bones, liver, lymph nodes or the bed where the kidney used to sit than in the opposite kidney. Your team works out which situation it is from the imaging, the pattern of disease elsewhere, the pathology of the original tumour and sometimes a biopsy. The two are managed differently, so it is worth asking your oncologist to say plainly which one is being described.

The recognised factors are an inherited kidney cancer syndrome such as VHL disease, hereditary leiomyomatosis and renal cell cancer, Birt-Hogg-Dube syndrome or hereditary papillary renal cell cancer; having had more than one tumour, or tumours in both kidneys, at the original diagnosis; a young age at first diagnosis; a strong family history; long-standing dialysis with acquired cystic kidney disease; and continuing to smoke. NCCN sets out who should be offered genetic counselling and testing, and that assessment is done in-house at CION. If none of these applies to you, your situation is the common one, where a second kidney cancer is not expected.

Almost always on a follow-up scan, before it causes anything you would notice. Cross-sectional imaging of the abdomen after kidney cancer treatment is not only checking the surgical bed; the remaining kidney is in the picture and is compared directly against your earlier scans, so a small new lesion stands out as a change. That is why old scans should travel with you as image files, not just printed reports. Between scans, visible blood in the urine even once, a one-sided ache that has not settled, or unexplained weight loss should be brought forward rather than saved for the next appointment.

That is not the starting assumption. When there is only one kidney left, the whole bias of planning shifts towards preserving it. Depending on the size, position and appearance of the lesion, the options discussed at the tumour board typically include watching a very small lesion closely, removing only the tumour and leaving the kidney in place, or destroying it with heat or cold. Removing part of a kidney and ablation are coordinated with specialist urology, uro-oncology and interventional radiology partner centres rather than performed in-house at CION. Losing the kidney entirely is discussed honestly where it is genuinely unavoidable, but it is the last option considered, not the first.

Longer than most people expect, and the schedule is set by your risk rather than by a single fixed rule. Follow-up along NCCN lines is risk-adapted: the stage and pathology of the original tumour decide how often you are imaged and for how many years, with the appointments closest together in the early years and spaced out later. If you have an inherited syndrome or had tumours in both kidneys, surveillance is usually more intensive and continues indefinitely, because in those conditions new tumours are part of the condition itself. Ask for your schedule in writing so you are not left guessing when the next scan is due.